Sunday saw the first-ever meeting between elite-level NFL quarterbacks Aaron Rodgers and Lamar Jackson. Rodgers and the Pittsburgh Steelers beat Jackson and the Baltimore Ravens 27-22, and in the ...
A century ago, two oddly domestic puzzles helped set the rules for what modern science treats as "real": a Guinness brewer charged with quality control and a British lady insisting she can taste ...
Have you ever spent hours crafting a timeline chart, only to abandon it because it was too clunky, rigid, or just plain uninspiring? You’re not alone. Many tools promise sleek visuals but fall short ...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) shared topline data from the ESSENCE Phase 3 trial of Amondys 45 (casimersen) and Vyondys 53 (golodirsen) compared with placebo in 225 patients aged 6-13 years ...
The perennial question facing all banks is, “What volume of lending in Majority-Minority census tracts and mortgages extended to minority home borrowers must we do to avoid redlining allegations by ...
Summit Therapeutics Inc. (NASDAQ:SMMT), on Sunday, revealed the updated overall survival (OS) results from the global Phase 3 HARMONi trial of ivonescimab at the 2025 World Conference on Lung Cancer ...
Akeso, Summit's PD-1xVEGF drug meets overall survival goal for the first time in a lung cancer trial
For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend patients’ lives. A “statistically significant and clinically meaningful” ...
-- Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback